SEC Comment Letter for KAZIA THERAPEUTICS LTD (KZIA) (CIK 0001075880) (KZIA) — Jun 17, 2010

KAZIA THERAPEUTICS LTD (KZIA) (CIK 0001075880)
Date: June 17, 2010 · CIK: 0001075880 · Accession: 0000000000-10-034186

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-29962

Date

June 17, 2010

Author

Joel Parker

Form

UPLOAD

Company

KAZIA THERAPEUTICS LTD (KZIA) (CIK 0001075880)

Letter

June 17, 2010 David Seaton Acting Chief Executive Officer and Chief Financial Officer Novogen Limited 140 Wicks Road North Ryde, New South Wales 2113 Australia Re: Novogen Limited Form 20-F for the Fiscal Year Ended June 30, 2009 Filed December 15, 2009 File Number: 000-29962

Dear Mr. Seaton: We have completed our review of your f iling and do not have any further comments at this time. Sincerely,

Joel Parker A c c o u n t i n g B r a n c h C h i e f

Show Raw Text

June 17, 2010
 David Seaton Acting Chief Executive Officer and  Chief Financial Officer Novogen Limited 140 Wicks Road North Ryde, New South Wales 2113 Australia
Re: Novogen Limited
   Form 20-F for the Fiscal Year Ended June 30, 2009
   Filed December 15, 2009
   File Number:  000-29962

Dear Mr. Seaton:
  We have completed our review of your f iling and do not have any further comments at
this time.
Sincerely,

Joel Parker
        A c c o u n t i n g  B r a n c h  C h i e f

SecProbe.io